The return on investment conversation for health technology and AI-powered applications has evolved over the years. Initially a sticky subject without a true answer, IT leaders in many organizations have been able to prove the value of soft ROI and lean into the discomfort of making big investments that indirectly influence the bottom line.

Becker’s Healthcare asked 60+ healthcare technology, financial, clinical and operational leaders about how their organizations measure and track technology ROI and 10 themes emerged, setting the tone for how they’ll evaluate future investments.

The leaders surveyed are speakers at the Becker’s 11th Annual Health IT + Digital Health + Revenue Cycle Conference, Sept. 14-17, 2026 in Chicago. Click here to learn more and register or sponsor.

1. ROI is multidimensional. Financial return is necessary, but not sufficient. The near-universal consensus among IT leaders was that healthcare technology ROI cannot be reduced to a payback period or an internal rate of return calculation. Leaders across the field structure their thinking across clinical, operational, financial, and experiential dimensions simultaneously. The organizations that have advanced furthest have built formal frameworks — scorecards, tiered value models, balanced metric sets — to make this multidimensionality legible to finance committees rather than leaving it as a philosophical disclaimer.

2. Reducing clinician burnout and administrative burden is a primary return. The reclamation of clinician time — from documentation, administrative tasks and the cognitive overhead of poorly designed workflows — is both a moral and financial imperative. Leaders said any technology that adds net burden to providers is not an innovation but technical debt, and the long-term cost of that debt — in turnover, in errors, in disengagement — routinely exceeds the paper savings that justified the investment. If physicians and nurses don’t get meaningful time back, the financial ROI tends to disappoint.

3. Adoption is the gating factor and deployment is not the same as value. A technology deployed but not used delivers a return of precisely zero. The most rigorous frameworks treat adoption and sustained workflow change as the true leading indicators that value will be realized, not go-live dates or license counts. Organizations that treat implementation as an afterthought will consistently underperform on their technology investments regardless of how sound the underlying solution is.

4. Define success criteria before you buy anything. The leaders most confident in their ROI frameworks share a common practice: they establish the business case, KPIs, and definition of success before procurement, not after. Technology investments fail most predictably when the problem being solved is unclear at the outset, leaving organizations automating broken processes rather than fixing them. The discipline of writing the business case with explicit objectives, scope, and measurable outcomes is the prerequisite for any honest ROI conversation.

5. AI requires a portfolio approach to tracking and measurement. Different categories of AI investment require fundamentally different ROI metrics. Table-stakes AI might be measured by staff satisfaction and retention, AI-enhanced workflows by efficiency and quality improvements, AI-imagined new care models by clinical outcomes like mortality and length of stay, and exploratory AI by its contribution to the innovation pipeline. Applying a single financial threshold across all AI investments will cause organizations to kill the most transformative bets while over-investing in incremental ones.

6. Risk reduction and cost avoidance must be quantified. Cybersecurity investments, patient safety tools, and regulatory compliance technology generate returns through costs and harms avoided rather than revenue generated, and these returns are chronically undervalued in ROI conversations. Preventing a serious adverse event, a ransomware disruption, or a regulatory penalty can dwarf the savings from efficiency-focused technology. The challenge is not recognizing this intellectually but building the analytical discipline to put numbers on avoided outcomes before the board, not after the incident.

7. The best technology disappears into the workflow. Truly valuable technology becomes invisible; it quietly removes friction rather than adding a new interface layer that clinicians must navigate around. If a solution is generating frequent complaints in the months after go-live, the end users are feeling frustrated by it instead of relieved. Organizations that consistently realize technology ROI treat workflow integration as a primary design constraint with the potential to unlock real value over time.

8. Trusted data and real-time analytics are the connective tissue. A consistent view is that technology without trusted data creates no value regardless of how capable the underlying tool is. The system-level return from technology accrues when clinical, operational, and financial leaders can act on high-quality, timely information, shifting institutions from reactive to proactive postures. Building that data foundation is often less visible than deploying a new application, but it is what determines whether the application’s ROI is theoretical or real.

9. Patient outcomes and access are the ultimate standard. Across clinical leaders in particular, there is a consistent anchoring of ROI definitions to measurable improvements in outcomes, access, and quality of life for patients with financial returns treated as instrumental, a means of sustaining the mission rather than the mission itself. Technologies that cannot demonstrate impact on those dimensions will eventually struggle to justify themselves regardless of their operational efficiencies. The ultimate measure of healthcare technology ROI is lives improved or saved.

10. Speed to value and total lifecycle cost both matter. The speed of value delivery is a component of ROI. An investment that doesn’t yield returns for two years costs the organization real capital in the intervening period and weakens the case for the next transformation initiative. IT leaders are now advocating for full lifecycle cost analysis of new technology that accounts for implementation, training, ongoing support, and optimization. Organizations that consistently win on technology ROI model both dimensions and build the organizational change capacity to accelerate realization, not just the analytical capacity to measure it.

The post 10 trends in healthcare tech investments and ROI appeared first on Becker’s Hospital Review | Healthcare News & Analysis.